APO Research
Talk to an analyst

APO RESEARCH · REPORT

Open-Angle Glaucoma Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Open-Angle Glaucoma Therapeutics Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchOpen-Angle Glaucoma Therapeutics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Open-Angle Glaucoma Therapeutics Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Open-Angle Glaucoma Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Open-Angle Glaucoma Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Open-Angle Glaucoma Therapeutics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Open-Angle Glaucoma Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Open-Angle Glaucoma Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Open-Angle Glaucoma Therapeutics market include Novartis AG, Pfizer Inc., Bausch Health Companies, Inc., Allergan Plc and Aerie Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Open-Angle Glaucoma Therapeutics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Open-Angle Glaucoma Therapeutics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Open-Angle Glaucoma Therapeutics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Open-Angle Glaucoma Therapeutics market.

Open-Angle Glaucoma Therapeutics Segment by Company

Novartis AG

Pfizer Inc.

Bausch Health Companies, Inc.

Allergan Plc

Aerie Pharmaceuticals Inc.

Open-Angle Glaucoma Therapeutics Segment by Type

Prostaglandin Analogs (PGAs)

Combination of PGAs

Other

Open-Angle Glaucoma Therapeutics Segment by Application

Clinic

Hospital

Research Institute

Other

Open-Angle Glaucoma Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Open-Angle Glaucoma Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Open-Angle Glaucoma Therapeutics key companies, revenue, market share, and recent developments.

3. To split the Open-Angle Glaucoma Therapeutics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Open-Angle Glaucoma Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Open-Angle Glaucoma Therapeutics significant trends, drivers, influence factors in global and regions.

6. To analyze Open-Angle Glaucoma Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Open-Angle Glaucoma Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Open-Angle Glaucoma Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Open-Angle Glaucoma Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Open-Angle Glaucoma Therapeutics industry.

Chapter 3: Detailed analysis of Open-Angle Glaucoma Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Open-Angle Glaucoma Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Open-Angle Glaucoma Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Open-Angle Glaucoma Therapeutics Industry Trends Table 2. Open-Angle Glaucoma Therapeutics Industry Drivers Table 3. Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges Table 4. Open-Angle Glaucoma Therapeutics Industry Restraints Table 5. Global Open-Angle Glaucoma Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Open-Angle Glaucoma Therapeutics Revenue Share by Company (2021-2026) Table 7. Global Open-Angle Glaucoma Therapeutics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Open-Angle Glaucoma Therapeutics Key Company Manufacturing Base & Headquarters Table 9. Global Open-Angle Glaucoma Therapeutics Company, Product Type & Application Table 10. Global Open-Angle Glaucoma Therapeutics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Open-Angle Glaucoma Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prostaglandin Analogs (PGAs) Table 15. Significant Companies of Combination of PGAs Table 16. Significant Companies of Other Table 17. Global Open-Angle Glaucoma Therapeutics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Open-Angle Glaucoma Therapeutics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Open-Angle Glaucoma Therapeutics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Type (2021-2026) Table 21. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Clinic Table 23. Significant Companies of Hospital Table 24. Significant Companies of Research Institute Table 25. Significant Companies of Other Table 26. Global Open-Angle Glaucoma Therapeutics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Open-Angle Glaucoma Therapeutics Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Open-Angle Glaucoma Therapeutics Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Application (2021-2026) Table 30. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Application (2027-2032) Table 31. Global Open-Angle Glaucoma Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Open-Angle Glaucoma Therapeutics Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Region (2021-2026) Table 34. Global Open-Angle Glaucoma Therapeutics Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Region (2027-2032) Table 36. Global Open-Angle Glaucoma Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Open-Angle Glaucoma Therapeutics Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Open-Angle Glaucoma Therapeutics Sales Value Market Share by Country (2021-2026) Table 39. Global Open-Angle Glaucoma Therapeutics Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Open-Angle Glaucoma Therapeutics Sales Value Market Share by Country (2027-2032) Table 41. Novartis AG Company Information Table 42. Novartis AG Business Overview Table 43. Novartis AG Open-Angle Glaucoma Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio Table 45. Novartis AG Recent Development Table 46. Pfizer Inc. Company Information Table 47. Pfizer Inc. Business Overview Table 48. Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 50. Pfizer Inc. Recent Development Table 51. Bausch Health Companies, Inc. Company Information Table 52. Bausch Health Companies, Inc. Business Overview Table 53. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 55. Bausch Health Companies, Inc. Recent Development Table 56. Allergan Plc Company Information Table 57. Allergan Plc Business Overview Table 58. Allergan Plc Open-Angle Glaucoma Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio Table 60. Allergan Plc Recent Development Table 61. Aerie Pharmaceuticals Inc. Company Information Table 62. Aerie Pharmaceuticals Inc. Business Overview Table 63. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 65. Aerie Pharmaceuticals Inc. Recent Development Table 66. Research Programs/Design for This Report Table 67. Authors List of This Report Table 68. Secondary Sources Table 69. Primary Sources List of Figures Figure 1. Open-Angle Glaucoma Therapeutics Product Image Figure 2. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Open-Angle Glaucoma Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Open-Angle Glaucoma Therapeutics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prostaglandin Analogs (PGAs) Image Figure 8. Combination of PGAs Image Figure 9. Other Image Figure 10. Global Open-Angle Glaucoma Therapeutics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Open-Angle Glaucoma Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Type (2021-2032) Figure 13. Clinic Image Figure 14. Hospital Image Figure 15. Research Institute Image Figure 16. Other Image Figure 17. Global Open-Angle Glaucoma Therapeutics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Open-Angle Glaucoma Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Application (2021-2032) Figure 20. Global Open-Angle Glaucoma Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Open-Angle Glaucoma Therapeutics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Open-Angle Glaucoma Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 23. North America Open-Angle Glaucoma Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Open-Angle Glaucoma Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Open-Angle Glaucoma Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Open-Angle Glaucoma Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Open-Angle Glaucoma Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Open-Angle Glaucoma Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 29. South America Open-Angle Glaucoma Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Open-Angle Glaucoma Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Open-Angle Glaucoma Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Prostaglandin Analogs (PGAs)
  • Combination of PGAs
  • Other
Applications
  • Clinic
  • Hospital
  • Research Institute
  • Other
Companies covered
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies, Inc.
  • Allergan Plc
  • Aerie Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Open-Angle Glaucoma Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Open-Angle Glaucoma Therapeutics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Open-Angle Glaucoma Therapeutics Market Dynamics
  1. 2.1 Open-Angle Glaucoma Therapeutics Industry Trends
  2. 2.2 Open-Angle Glaucoma Therapeutics Industry Drivers
  3. 2.3 Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges
  4. 2.4 Open-Angle Glaucoma Therapeutics Industry Restraints
3 Open-Angle Glaucoma Therapeutics Market by Company
  1. 3.1 Global Open-Angle Glaucoma Therapeutics Company Revenue Ranking in 2025
  2. 3.2 Global Open-Angle Glaucoma Therapeutics Revenue by Company (2021-2026)
  3. 3.3 Global Open-Angle Glaucoma Therapeutics Company Ranking (2024-2026)
  4. 3.4 Global Open-Angle Glaucoma Therapeutics Company Manufacturing Base and Headquarters
  5. 3.5 Global Open-Angle Glaucoma Therapeutics Company Product Type and Application
  6. 3.6 Global Open-Angle Glaucoma Therapeutics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Open-Angle Glaucoma Therapeutics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Open-Angle Glaucoma Therapeutics Market by Type
  1. 4.1 Open-Angle Glaucoma Therapeutics Type Introduction
  2. 4.1.1 Prostaglandin Analogs (PGAs)
  3. 4.1.2 Combination of PGAs
  4. 4.1.3 Other
  5. 4.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Type
  6. 4.2.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Open-Angle Glaucoma Therapeutics Sales Value Share by Type (2021-2032)
5 Open-Angle Glaucoma Therapeutics Market by Application
  1. 5.1 Open-Angle Glaucoma Therapeutics Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Institute
  5. 5.1.4 Other
  6. 5.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Application
  7. 5.2.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Application (2021-2032)
  9. 5.2.3 Global Open-Angle Glaucoma Therapeutics Sales Value Share by Application (2021-2032)
6 Open-Angle Glaucoma Therapeutics Regional Value Analysis
  1. 6.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Open-Angle Glaucoma Therapeutics Sales Value (2021-2032)
  7. 6.3.2 North America Open-Angle Glaucoma Therapeutics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Open-Angle Glaucoma Therapeutics Sales Value (2021-2032)
  10. 6.4.2 Europe Open-Angle Glaucoma Therapeutics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Open-Angle Glaucoma Therapeutics Sales Value (2021-2032)
  16. 6.6.2 South America Open-Angle Glaucoma Therapeutics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Sales Value Share by Country, 2025 VS 2032
7 Open-Angle Glaucoma Therapeutics Country-level Value Analysis
  1. 7.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Open-Angle Glaucoma Therapeutics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Open-Angle Glaucoma Therapeutics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Open-Angle Glaucoma Therapeutics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Open-Angle Glaucoma Therapeutics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Open-Angle Glaucoma Therapeutics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 Bausch Health Companies, Inc.
  14. 8.3.1 Bausch Health Companies, Inc. Company Information
  15. 8.3.2 Bausch Health Companies, Inc. Business Overview
  16. 8.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  18. 8.3.5 Bausch Health Companies, Inc. Recent Developments
  19. 8.4 Allergan Plc
  20. 8.4.1 Allergan Plc Company Information
  21. 8.4.2 Allergan Plc Business Overview
  22. 8.4.3 Allergan Plc Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio
  24. 8.4.5 Allergan Plc Recent Developments
  25. 8.5 Aerie Pharmaceuticals Inc.
  26. 8.5.1 Aerie Pharmaceuticals Inc. Company Information
  27. 8.5.2 Aerie Pharmaceuticals Inc. Business Overview
  28. 8.5.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  30. 8.5.5 Aerie Pharmaceuticals Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst